|
Winter 2009 |
|
Laura Knapp, the Director of Clinical Trials for Monteris Medical, contacted the support group to let us know about a new clinical trial for people with recurrent or progressive glioblastoma multiforme brain tumors. The trial evaluates a new device-based approach to destroying brain tumors. The device is an MRI-guided laser probe, slightly larger than a biopsy needle that is inserted into a tumor following a biopsy. When activated, the laser heats the tumor to the point of coagulation (approximately 60° C), which destroys it almost immediately. The procedure is con |





New Clinical Trial from Monteris Medical, Inc. |




